Back
Aurinia Pharmaceuticals 10K Form
Buy
58
AUPH
Aurinia Pharmaceuticals
Last Price:
$9.08
Seasonality Move:
-5.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2023-11-02 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2023-08-03 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2023-05-04 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
| 2022-08-04 | 10Q | AUPH/Aurinia Pharmaceuticals Quarterly |
Receive AUPH News And Ratings
See the #1 stock for the next 7 days that we like better than AUPH
AUPH Financial Statistics
Sales & Book Value
| Annual Sales: | $235.1M |
|---|---|
| Cash Flow: | $1.3M |
| Price / Cash Flow: | 20 |
| Annual Sales: | $2.54 |
| Price / Book: | 3.41 |
Profitability
| EPS (TTM): | 0.28000 |
|---|---|
| Net Income (TTM): | $39.8M |
| Gross Margin: | $206.9M |
| Return on Equity: | 10.83% |
| Return on Assets: | 7.53% |
Aurinia Pharmaceuticals Earnings Forecast
Key Aurinia Pharmaceuticals Financial Ratios
-
The Gross Profit Margin over the past 27 years for AUPH is 87.99%.
-
The Selling, General & Administrative Expenses for AUPH have been equal to 73.16% of Gross Profit Margin.
-
The Research & Development expenses have been 8.84% of Revenue.
-
The Interest Expense is 84.06% of Operating Income.
-
The Net Earning history of AUPH is 2.45% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 15 years.
Aurinia Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AUPH |
| CUSIP: | 05156V |
| Website: | auriniapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.93 |
| Quick Ratio: | 5.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 221.25 |
|---|---|
| Forward P/E Ratio: | 11.68 |
AUPH Technical Analysis vs Fundamental Analysis
Buy
58
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a BuyThe current Aurinia Pharmaceuticals [AUPH] share price is $8.85. The Score for AUPH is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.